Medical Devices APAC

APAC Neonatal Intensive Care Equipment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Neonatal Intensive Care Equipment Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $508.7 Mn Placeholder estimate
Estimate 2025 $548.9 Mn 19.2% of the global market
Projected 2034 $1.09 Bn 98.2% Adds $539.3 Mn over 9 forecast years
CAGR 2025–2034 7.9% Faster than 24% of 193 Medical Devices markets here
Key players 5
  • APAC is 19.18% of the global market.
  • Among regions, the largest is North America at $1.58 Bn.
  • Fastest growing: Africa at 8.3% a year.
  • APAC ranks 3rd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$539.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Neonatal Intensive Care Equipment Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $508.7 Mn — —
2025 (base) $548.9 Mn +$40.2 Mn —
2026 (forecast) $592.3 Mn +$43.4 Mn +7.9%
2027 (forecast) $639.1 Mn +$46.8 Mn +16.4%
2028 (forecast) $689.6 Mn +$50.5 Mn +25.6%
2029 (forecast) $744.1 Mn +$54.5 Mn +35.5%
2030 (forecast) $802.8 Mn +$58.8 Mn +46.3%
2031 (forecast) $866.3 Mn +$63.4 Mn +57.8%
2032 (forecast) $934.7 Mn +$68.4 Mn +70.3%
2033 (forecast) $1.01 Bn +$73.8 Mn +83.7%
2034 (forecast) $1.09 Bn +$79.7 Mn +98.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Neonatal Intensive Care Equipment Market Analysis at a glance
Market size, 2025$548.9 Mn placeholder estimate
Forecast, 2034$1.09 Bn placeholder estimate
Growth (CAGR), 2025–20347.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledNeonatal Intensive Care
SegmentsProduct, setting and end user (see all)
Key playersGE Healthcare, Draegerwerk, Philips Healthcare, Atom Medical, Phoenix Medical Systems (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Neonatal Intensive Care Equipment Market Analysis Executive Summary

Neonatal intensive care equipment keeps premature and sick newborns warm, breathing and monitored.

Key segments of the neonatal Intensive Care Equipment market include product (Incubators and Warmers, Neonatal Ventilators and Phototherapy Units) and setting (Level III and IV NICUs and Level II Units).

Bar chart: Asia Pacific Neonatal Intensive Care Equipment market size, 2024–2034, placeholder estimates. $508.7 Mn in 2024, $548.9 Mn in 2025 and $1.09 Bn in 2034, 7.9% CAGR.
Asia Pacific Neonatal Intensive Care Equipment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Neonatal Intensive Care Equipment Market Dynamics

Market Growth Drivers

An ageing population, more screening, better implant technology and greater awareness of hearing and child health needs are driving the neonatal Intensive Care Equipment market.

Opportunity

Over-the-counter options, tele-audiology and programmes in emerging markets give the neonatal Intensive Care Equipment market room to grow.

Market Restraints

High costs, limited insurance coverage and a shortage of specialists hold back the neonatal Intensive Care Equipment market.

Competitive Landscape for Neonatal Intensive Care Equipment Market in APAC

The neonatal Intensive Care Equipment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Neonatal Intensive Care Equipment Market in APAC

Neonatal Intensive Care Equipment in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9], Thai FDA (Thailand)⁠[10], Ministry of Health (Indonesia)⁠[11], DRAP (Pakistan)⁠[12], MFDS (South Korea)⁠[13] and Ministry of Health (Vietnam)⁠[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[15], basic medical insurance (China)⁠[16], the Hospital Authority (Hong Kong)⁠[17], Ayushman Bharat PM-JAY (India)⁠[18], public health insurance (Japan)⁠[19], subsidised public care (Malaysia)⁠[20], Pharmac (New Zealand)⁠[21], PhilHealth (Philippines)⁠[22], MediShield Life (Singapore)⁠[23], the Universal Coverage Scheme (Thailand)⁠[24], JKN (BPJS Kesehatan) (Indonesia)⁠[25], out of pocket and Sehat Sahulat (Pakistan)⁠[26], National Health Insurance (South Korea)⁠[27] and social health insurance (Vietnam)⁠[28].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Ministry of Health of Indonesia. Checked 19 Nov 2026.

[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.

[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.

[14] Ministry of Health of Vietnam. Checked 19 Nov 2026.

[15] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[16] National Healthcare Security Administration. Checked 14 Nov 2026.

[17] Hospital Authority. Checked 14 Nov 2026.

[18] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[19] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[20] Ministry of Health Malaysia. Checked 14 Nov 2026.

[21] Pharmac. Checked 14 Nov 2026.

[22] PhilHealth. Checked 14 Nov 2026.

[23] CPF Board, MediShield Life. Checked 14 Nov 2026.

[24] National Health Security Office. Checked 14 Nov 2026.

[25] BPJS Kesehatan. Checked 19 Nov 2026.

[26] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.

[27] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.

[28] Vietnam Social Security. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neonatal Intensive Care Equipment products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Neonatal Intensive Care Equipment right now, from free public sources.

Patients

Newborn deaths (first 28 days), per 1,000 live births (World Bank)
CountryValueYear
Afghanistan33.12024
Australia2.32024
Bangladesh17.92024
China2.62024
India16.72024
Indonesia9.22024
Japan0.92024
Malaysia4.32024
Myanmar19.62024
Nepal15.32024
New Zealand2.72024
Pakistan36.12024
Philippines13.62024
Singapore1.12024
South Korea1.22024
Thailand5.12024
Vietnam8.82024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 22 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Neonatal Intensive Care Equipment in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Neonatal Intensive Care Equipment market in Asia Pacific?
Placeholder estimate: about $548.9 Mn in 2025, rising to about $1.09 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Neonatal Intensive Care Equipment market in Asia Pacific growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Neonatal Intensive Care Equipment market report cover?
The report splits the market by product (Incubators and Warmers, Neonatal Ventilators, Phototherapy Units, Neonatal Monitors), setting (Level III and IV NICUs, Level II Units) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Neonatal Intensive Care Equipment market?
Key players include GE Healthcare, Draegerwerk, Philips Healthcare, Atom Medical and Phoenix Medical Systems.
What is driving the Neonatal Intensive Care Equipment market?
An ageing population, more screening, better implant technology and greater awareness of hearing and child health needs are driving the neonatal Intensive Care Equipment market.
How much research is published on Neonatal Intensive Care Equipment?
PubMed lists 653 papers on Neonatal Intensive Care Equipment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on neonatal and pediatric

See the topic